glp 1 agonist 종류 GLP-1수용체작용제 (Glucagon-like peptide -1 receptor agonist) > 당뇨병 관리 차세대 당뇨약 GLP-1 수용체 작용제
Description
Meals with more protein lead to a much higher GLP-1 response
However, in SURPASS-5, individuals on a background of insulin glargine and tirzepatide reported serious hypoglycemia (19%) more than individuals on a background of insulin glargine and placebo (13%) [14]
Follow-up: Minimum follow-up duration of 6 months
Advancements in Drug Delivery Advancements in drug delivery play a major role in driving the market forward
10.1007/s40265-023-01932-2 66
doi:10.1001/jama.2021.23619 107
